Antibody discovery companies develop platforms and services for identifying antibodies used in therapeutics, diagnostics and life science research. Their technologies support candidate discovery, screening, optimisation and early development.
This category includes companies working on:
Browse 63 UK antibody discovery companies below.
Integrated CRO services from drug discovery to manufacture
Charles River Laboratories is a global contract research organisation providing integrated preclinical drug discovery and development services to pharmaceutical, biotechnology and…
Proprietary phage display platform for therapeutic antibody discovery
RxBiologics is a Cambridge-based antibody discovery CRO and subsidiary of RxCelerate. Its proprietary phage display library platform incorporates in-line optimisation technology…
ML-driven antibody discovery platform for solid tumour therapeutics
LabGenius Therapeutics is a company developing next-generation therapeutic antibodies using its closed-loop machine learning platform. The platform integrates AI, robotic…
Bioanalytical instruments and automation for drug discovery research
Molecular Devices is a provider of high-performance bioanalytical measurement instruments, software, and consumables for life science research and pharmaceutical development. The…
Global biologics CDMO for vaccines, antibodies, and advanced therapies
FUJIFILM Biotechnologies is a contract development and manufacturing organisation providing process development and cGMP manufacturing of biologics, vaccines, and cell and gene…
AI-designed antibody biologics adapting human therapeutics for companion animals
Antigenesis Biologics is a biotechnology company developing targeted biological treatments for companion animals, applying expertise in human antibody therapeutics to address a…
Antibody therapy to deplete amyloid deposits in ATTR cardiomyopathy
Immutrin is a biotechnology company developing an engineered antibody therapeutic designed to actively remove amyloid deposits from tissues in patients with amyloidosis. Its lead…
Antibodies, proteins, and molecular reagents for life science research
ABclonal UK is the British subsidiary of a global life science tools and services group, supplying research reagents and custom development services to academic, diagnostic, and…
Immuno-oncology target discovery and antibody therapeutics developer
4C Biomed is a biotechnology company developing immuno-oncology therapies and target discovery platforms based on patient-derived tumour and immune cell systems. The company uses…
End-to-end antibody discovery and development services for global biopharma
FairJourney Biologics is a contract research organisation providing integrated antibody discovery, engineering, production and characterisation services to pharmaceutical and…
Bispecific antibody-drug conjugates for hard-to-treat solid tumours
Valink Therapeutics is a biotechnology company developing next-generation bispecific antibody-drug conjugates and multispecific antibody therapeutics for oncology. Its proprietary…
End-to-end lateral flow immunoassay development and manufacturing
Global Access Diagnostics (GADx) is a contract developer and manufacturer of rapid lateral flow immunoassay tests for human, veterinary, and agricultural applications. Operating…